BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8972469)

  • 1. Proliferative activity, angiogenesis, and necrosis in peripheral nerve sheath tumors: a quantitative evaluation for prognosis.
    Miracco C; Montesco MC; Santopietro R; Spina D; d'Amore ES; Tosi P; Ninfo V
    Mod Pathol; 1996 Dec; 9(12):1108-17. PubMed ID: 8972469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediastinal tumors of peripheral nervous system origin.
    Marchevsky AM
    Semin Diagn Pathol; 1999 Feb; 16(1):65-78. PubMed ID: 10355655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary study regarding the utility of certain immunohistochemical markers in diagnosing neurofibromas and schwannomas.
    Ghiluşi M; Pleşea IE; Comănescu M; Enache SD; Bogdan F
    Rom J Morphol Embryol; 2009; 50(2):195-202. PubMed ID: 19434310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.
    Nabeshima K; Iwasaki H; Nishio J; Koga K; Shishime M; Kikuchi M
    Anticancer Res; 2006; 26(2B):1359-67. PubMed ID: 16619545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral nerve sheath tumors of the head and neck.
    Bruner JM
    Semin Diagn Pathol; 1987 May; 4(2):136-49. PubMed ID: 3313599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathologic characteristics of the most frequent peripheral nerve tumors].
    Coulon A; Milin S; Laban E; Debiais C; Jamet C; Goujon JM
    Neurochirurgie; 2009 Oct; 55(4-5):454-8. PubMed ID: 19744677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic classification of peripheral nerve tumors.
    Skovronsky DM; Oberholtzer JC
    Neurosurg Clin N Am; 2004 Apr; 15(2):157-66. PubMed ID: 15177315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actin expression in neural crest cell-derived tumors including schwannomas, malignant peripheral nerve sheath tumors, neurofibromas and melanocytic tumors.
    Dundr P; Povýsil C; Tvrdík D
    Pathol Int; 2009 Feb; 59(2):86-90. PubMed ID: 19154261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 and Ki-67 proliferating cell nuclear antigen in benign and malignant peripheral nerve sheath tumors in children.
    Liapis H; Marley EF; Lin Y; Dehner LP
    Pediatr Dev Pathol; 1999; 2(4):377-84. PubMed ID: 10347283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.
    Jokinen CH; Dadras SS; Goldblum JR; van de Rijn M; West RB; Rubin BP
    Am J Clin Pathol; 2008 Jun; 129(6):886-93. PubMed ID: 18480004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroperitoneal nerve sheath tumors: an unusual cause of pelvic mass.
    Hunter VP; Burke TW; Crooks LA
    Obstet Gynecol; 1988 Jun; 71(6 Pt 2):1050-2. PubMed ID: 3374919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein D is down-regulated during malignant transformation of neurofibromas.
    Hunter S; Weiss S; Ou CY; Jaye D; Young A; Wilcox J; Arbiser JL; Monson D; Goldblum J; Nolen JD; Varma V
    Hum Pathol; 2005 Sep; 36(9):987-93. PubMed ID: 16153462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis.
    Koga T; Iwasaki H; Ishiguro M; Matsuzaki A; Kikuchi M
    J Pathol; 2002 May; 197(1):98-107. PubMed ID: 12081210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant peripheral nerve sheath tumor of the breast: case report.
    Dhingra KK; Mandal S; Roy S; Khurana N
    World J Surg Oncol; 2007 Dec; 5():142. PubMed ID: 18154670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign nerve sheath tumors on urinary bladder biopsy.
    Wang W; Montgomery E; Epstein JI
    Am J Surg Pathol; 2008 Jun; 32(6):907-12. PubMed ID: 18425043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nestin expression as a new marker in malignant peripheral nerve sheath tumors.
    Shimada S; Tsuzuki T; Kuroda M; Nagasaka T; Hara K; Takahashi E; Hayakawa S; Ono K; Maeda N; Mori N; Illei PB
    Pathol Int; 2007 Feb; 57(2):60-7. PubMed ID: 17300669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AgNOR expression in CNS neoplasms.
    Husain N; Bagchi M; Husain M; Tiwari B
    Indian J Pathol Microbiol; 1997 Oct; 40(4):503-9. PubMed ID: 9444862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Malignant Peripheral Nerve Sheath Tumor.
    Luzar B; Falconieri G
    Surg Pathol Clin; 2017 Jun; 10(2):337-343. PubMed ID: 28477884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.
    Nonaka D; Chiriboga L; Rubin BP
    J Cutan Pathol; 2008 Nov; 35(11):1014-9. PubMed ID: 18547346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of phosphorylated signal transducer and activator of transcription 3 (pSTAT3) in peripheral nerve sheath tumours.
    Panse G; Leung CH; Ingram DR; Wani K; Torres KE; Lin H; Lazar AJ; Wang WL
    Histopathology; 2017 May; 70(6):946-953. PubMed ID: 27992966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.